Cargando…
Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396203/ https://www.ncbi.nlm.nih.gov/pubmed/32743771 http://dx.doi.org/10.1208/s12248-020-00483-8 |
| _version_ | 1783565543108771840 |
|---|---|
| author | Sun, Duxin |
| author_facet | Sun, Duxin |
| author_sort | Sun, Duxin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7396203 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73962032020-08-03 Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit Sun, Duxin AAPS J Correction Springer International Publishing 2020-08-02 /pmc/articles/PMC7396203/ /pubmed/32743771 http://dx.doi.org/10.1208/s12248-020-00483-8 Text en © American Association of Pharmaceutical Scientists 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correction Sun, Duxin Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit |
| title | Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit |
| title_full | Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit |
| title_fullStr | Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit |
| title_full_unstemmed | Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit |
| title_short | Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit |
| title_sort | correction to: remdesivir for treatment of covid-19: combination of pulmonary and iv administration may offer additional benefit |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396203/ https://www.ncbi.nlm.nih.gov/pubmed/32743771 http://dx.doi.org/10.1208/s12248-020-00483-8 |
| work_keys_str_mv | AT sunduxin correctiontoremdesivirfortreatmentofcovid19combinationofpulmonaryandivadministrationmayofferadditionalbenefit |